Secret dance in Parkinson's disease: In situ structure determination of a pathological mutant of LRRK2 bound to microtubules

被引：0

作者：

Audagnotto, Martina ^{[2
]}

Lasker, Keren ^{[1
]}

Castillon, Reika Watanabe ^{[2
]}

Amaro, Rommie ^{[2
]}

Buschauer, Robert ^{[4
]}

Bohning, Jan ^{[5
]}

Boassa, Daniela ^{[6
]}

Taylor, Susan ^{[7
]}

Villa, Elizabeth ^{[3
]}

机构：

[1] Stanford Med, Dev Biol, San Francisco, CA USA

[2] Univ Calif San Diego, Chem & Biochem, San Clemente, CA USA

[3] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA

[4] Univ Munich, Gene Ctr, Munich, Germany

[5] Univ Oxford, Sir William Sch Pathol, Oxford, England

[6] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92103 USA

[7] Univ Calif, Leichtag 412,MC 0654, La Jolla, CA USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

376-COMP

引用

页数：2

共 50 条

[31] LRRK2 is reduced in Parkinson’s disease gut
Adrien de Guilhem de Lataillade
Jérémy Verchere
Thibauld Oullier
Alice Prigent
Tony Durand
Carolina Pellegrini
Michel Neunlist
Thierry Baron
Malvyne Rolli-Derkinderen
Pascal Derkinderen
Acta Neuropathologica, 2021, 142 : 601 - 603
[32] Mutations in LRRK2 as a cause of Parkinson's disease
Giasson, Benoit I.
Van Deerlin, Vivianna M.
NEUROSIGNALS, 2008, 16 (01) : 99 - 105
[33] LRRK2, lysosome damage, and Parkinson's disease
Bentley-DeSousa, Amanda
Clegg, Devin
Ferguson, Shawn M.
CURRENT OPINION IN CELL BIOLOGY, 2025, 93
[34] The Cell Biology of LRRK2 in Parkinson's Disease
Usmani, Ahsan
Shavarebi, Farbod
Hiniker, Annie
MOLECULAR AND CELLULAR BIOLOGY, 2021, 41 (05)
[35] LRRK2 is reduced in Parkinson's disease gut
de Guilhem de Lataillade, Adrien
Verchere, Jeremy
Oullier, Thibauld
Prigent, Alice
Durand, Tony
Pellegrini, Carolina
Neunlist, Michel
Baron, Thierry
Rolli-Derkinderen, Malvyne
Derkinderen, Pascal
ACTA NEUROPATHOLOGICA, 2021, 142 (03) : 601 - 603
[36] Lrrk2 pathogenic substitutions in Parkinson's disease
Mata, IF
Kachergus, JM
Taylor, JP
Lincoln, S
Aasly, J
Lynch, T
Hulihan, MM
Cobb, SA
Wu, RM
Lu, CS
Lahoz, C
Wszolek, ZK
Farrer, MJ
NEUROGENETICS, 2005, 6 (04) : 171 - 177
[37] Lrrk2 pathogenic substitutions in Parkinson's disease
Ignacio F. Mata
Jennifer M. Kachergus
Julie P. Taylor
Sarah Lincoln
Jan Aasly
Timothy Lynch
Mary M. Hulihan
Stephanie A. Cobb
Ruey-Meei Wu
Chin-Song Lu
Carlos Lahoz
Zbigniew K. Wszolek
Matthew J. Farrer
Neurogenetics, 2005, 6 : 171 - 177
[38] LRRK2 as a therapeutic target in Parkinson's disease
Tan, E. K.
Schapira, A. H.
EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
[39] Targeting LRRK2 mutations in Parkinson's disease
Lesniak, Robert K.
Nichols, Robert Jeremy
Smith, Mark
Montine, Thomas J.
FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1167 - 1170
[40] LRRK2 and the Endolysosomal System in Parkinson's Disease
Erb, Madalynn L.
Moore, Darren J.
JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1271 - 1291

← 1 2 3 4 5 →